Albireo Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
58.67
|
|
Average Rating
|
4.86
|
|
# Strong Buys
|
6
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.06
|
-1.92
|
-0.86
|
-81.13%
|
|
2022-06-30
|
-1.65
|
-2.04
|
-0.39
|
-23.64%
|
|
2022-03-31
|
-1.85
|
-2.19
|
-0.34
|
-18.38%
|
|
2021-12-31
|
-1.35
|
-0.57
|
0.78
|
57.78%
|
|
2021-09-30
|
-0.38
|
2.90
|
3.28
|
863.16%
|
|
2021-06-30
|
-1.97
|
-1.90
|
0.07
|
3.55%
|
|
2021-03-31
|
-1.77
|
-2.29
|
-0.52
|
-29.38%
|
|
2020-12-31
|
-1.94
|
-1.30
|
0.64
|
32.99%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.15
|
|
2021-12-31
|
-1.86
|
|
2020-12-31
|
-6.87
|
|
2019-12-31
|
-5.04
|
|
2018-12-31
|
-3.88
|
|
2017-12-31
|
-3.20
|
|
2016-12-31
|
-5.86
|
|
2015-12-31
|
-10.55
|
|
2014-12-31
|
-22.20
|
|
2013-12-31
|
-36.00
|
|
2012-12-31
|
-49.20
|
|
2011-12-31
|
-42.00
|
|
2010-12-31
|
-158.40
|
|
2009-12-31
|
-224.40
|
|
2008-12-31
|
-217.20
|
|
2007-12-31
|
-365.81
|